1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Russia Pharmaceuticals and Healthcare Report Q3 2016

Russia Pharmaceuticals and Healthcare Report Q3 2016

  • June 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates

BMI View: Russia's healthcare market is in a precarious position due to a severe lack of funding and anescalating burden of disease. The country's economic recession will see further pressure placed on thepopulation for provision of care. Amendments to Russia's pharmaceutical legislation will, however, favourdomestically-produced medicines over foreign drugmakers and multinational drugmakers will be pressuredto establish a domestic manufacturing presence to comply with related new regulations. Nonetheless, givenits sheer market size and unmet potential, the country will remain attractive for investment by multinationalpharmaceutical firms for long-term growth.

Headline Expenditure Projections

- Pharmaceuticals: RUB1.0trn (USD16.6bn) in 2015 to RUB1.2trn (USD16.8bn) in 2016; +18.9% inlocal currency terms and +1.1% in US dollar terms. Forecast unchanged from last quarter.

- Healthcare: RUB5.4trn (USD88.2bn) in 2015 to RUB5.7trn (USD78.5bn) in 2016; +4.8% in localcurrency terms and -10.9% in US dollar terms. Forecast downgraded from last quarter.

Table Of Contents

Russia Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Russia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Russia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Russia 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Russia 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Russia 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Russia 2014-2020) 29
Industry Risk/Reward Index 30
Central And Eastern Europe Risk/Reward Index - Q3 2016 30
Russia Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 38
Intellectual Property Issues 40
Pricing Regime 43
Reimbursement Regime 47
Market Overview 48
Healthcare Sector 49
Table: Healthcare Resources (Russia 2010-2015) 50
Table: Healthcare Personnel (Russia 2010-2015) 50
Table: Healthcare Activity (Russia 2010-2015) 51
Research and Development 51
Clinical Trials 52
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Retail Sector 62
Company Profile 64
Johnson and Johnson 64
Novartis 67
Pharmstandard 71
Veropharm 75
Demographic Forecast 77
Demographic Outlook 77
Table: Population Headline Indicators (Russia 1990-2025) 78
Table: Key Population Ratios (Russia 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Russia 1990-2025) 79
Table: Population By Age Group (Russia 1990-2025) 79
Table: Population By Age Group % (Russia 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.